SuicidePhase 1NCT06547008
Army-SPRING Army-Suicide Prevention Research
A Phase 1 study testing Army-SPRING in people with Suicide, run by University of Pennsylvania at 3 sites in United States.
Trial summary
Every unit in the Connecticut Army National Guard has a Suicide Intervention Officer to provide suicide intervention education awareness for their unit, monitor for soldiers in crisis and connect soldiers with helping resources and agencies. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Suicide
- What is being tested?
- Army-SPRING
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 57 participants
- Where
- 3 sitesUnited States
- Study dates
- 19 Mar 2025to Aug 2028
- Phase
- Phase 1
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Serving as an SIO or chaplain/religious affairs specialist for a unit of the CTARNG
- Willing to provide informed consent.
Who cannot join
- None
Trial locations and contacts
3 sites in 1 country. Contact the study team or a site near you to ask about taking part.
United States3 sites, 2 recruiting
- Not yet recruiting
Connecticut Army National Guard
Hartford, Connecticut, 06103
Laura Stamatien, BS, 860-391-3799, laura.e.stamatien.mil@army.mil
- Active, not recruiting
Yale University
New Haven, Connecticut, 06520
- Recruiting
Center for the Treatment and Study of Anxiety, University of Pennsylvania
Philadelphia, Pennsylvania, 19104
Lily A Brown, PhD, 215-746-3346, lilybr@pennmedicine.upenn.edu
Marin Kautz, PhD, 8052357100, marin.kautz@pennmedicine.upenn.edu
About this study
Official title: Army-Suicide Prevention Research on Implementation in the National Guard (Army-SPRING)
Every unit in the Connecticut Army National Guard has a Suicide Intervention Officer to provide suicide intervention education awareness for their unit, monitor for soldiers in crisis and connect soldiers with helping resources and agencies. Suicide Intervention Officers need support in this difficult role, yet there is limited guidance on how to help them. This study will shed light on how to support Suicide Intervention Officers and whether this support results in reduced suicide risk in their units.
Read the detailed description
Attachment 4: Lay Abstract Objective 1: The first objective is to spend 6 months collecting feedback from Army National Guard Soldiers and their family, the religious affairs team, and leadership on how best to reduce risk for suicide. We will also collect feedback from Suicide Intervention Officers, who are appointed to reduce risk for suicide in their unit, about how to support these officers in their important work.
Objective 2: The second objective is to compare two strategies to support Suicide Intervention Officers as they work closely with soldiers to reduce their risk for suicide. The 47 Suicide Intervention Officers in the Connecticut Army National Guard will be randomly assigned (like the flip of a coin) to one of two groups. The first group will attend an extra training (Control Group). The second group will become part of a community focused on reducing suicide risk, including access to online forums to support them in their work, support in leading Battle Drills focused on suicide prevention, and additional training and consultation (Army-SPRING Group). Chaplains/religious affairs specialists will also receive the Army-SPRING group training, but will not be randomized since there are only 5 total Chaplains and 5 religious affairs specialists.
Objective 3: The third objective is to study whether soldiers with Suicide Intervention Officers in the Army-SPRING Group (described in objective 2) report lower rates of suicide ideation and attempts than the Control Group.
Rationale: Every unit in the Connecticut Army National Guard has a Suicide Intervention Officer to provide suicide intervention education awareness for their unit, monitor for soldiers in crisis and connect soldiers with helping resources and agencies. Suicide Intervention Officers need support in this difficult role, yet there is limited guidance on how to help them. This study will shed light on how to support Suicide Intervention Officers and whether this support results in reduced suicide risk in their units.
CBPR Approach and Implementation: We have formed a community advisory board that includes Veterans of Army National Guard units in other states (Pennsylvania); Veterans of the Army with employment as a civilian in the Marines, Chaplains in the Connecticut National Guard on the Air Force (who are intimately familiar with the needs at CT but who are not employees of the Army National Guard), and members of the Suicide Prevention Task force. We have asked for their feedback on the design of the study and will meet with them monthly for the three months and then quarterly thereafter.
FY23 TBIPHRP HSRA Focus Area: This project relates to the Prevent and Assess area of encouragement namely: "Development, evaluation, and implementation of crosscutting prevention approaches targeting upstream factors or leveraging communities and peers to address multiple adverse outcomes such as suicide." Types of Patients Helped by the Research and How it will Help Them: This research will help Army National Guard Soldiers, who are at higher risk for suicide than Active Duty service members. It will help them by supporting Suicide Intervention Officers as they work to reduce risk for suicide among soldiers.
Potential clinical applications, Benefits and Risks: The clinical application is a strategy to support Suicide Intervention Officers, which could benefit soldiers in reducing their suicide risk.
Projected timeline: 4 years, including 6 months of preparatory work with our community advisory board, who will also provide input throughout.
Health and well-being of Service Members: This will help the health and well-being of service members by reducing their risk for suicide. It will help Suicide Intervention Officers by improving their confidence in supporting soldiers who are struggling with suicide risk. It will help Chaplains/Religious affairs specialists who regularly desire more training in suicide prevention and who are a well-used source of support for soldiers at risk.
- Conditions
- Suicide
- Being tested
- Army-SPRING, Risk Reduction Group (Control)
- Keywords
- suicide, military
- Medical subject headings
- Suicide
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Army-SPRINGBehavioural
Army-SPRING includes a package of implementation options to support implementation of suicide prevention duties
Risk Reduction Group (Control)Behavioural
Risk Reduction Group is a mandated training from National Guard Service members
| Study group | Role | What they receive |
|---|---|---|
| Army-SPRING | Experimental | Army-SPRING includes a package of implementation options to support implementation of suicide prevention duties Receives: Behavioral: Army-SPRING |
| Risk Reduction Group (Control) | Placebo comparator | Risk Reduction Group is a mandated training from National Guard Service members Receives: Behavioral: Risk Reduction Group (Control) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reach - Self
Use of suicide prevention services for self, URI-3 item 75
Measured: Year 1
Reach - Intervening for others
Use of suicide prevention services for buddy, URI-3 item 74
Measured: Year 1
Reach - Interactions with soldiers involving discussions about suicide risk
Number of soldier interactions reporting suicide risk/Total number of interactions with soldiers
Measured: Weekly for 1 year
Secondary outcomes (8)
Suicidal ideation
URI-3 item 15
Measured: Year 1
Suicide plans:
URI-3 item 15a
Measured: Year 1
Suicide attempts
URI-3 item 15b
Measured: Year 1
Adoption
Suicide intervention officer willingness to initiate all SIO duties; This will be operationalized as the total number of SIOs who reported willingness to complete all their suicide prevention-related activities
Measured: Up to 24 months
Implementation
Fidelity to all assigned suicide intervention officer duties; Fidelity will be assessed using self-report by the SIO, including the following questions: 1) Does your battalion know that you are their SIO?; and 2) Have you completed any trainings related to suicide prevention with your battalion? Finally, among SIOs randomized to ARMY-SPRING, we will assess their fidelity of leading the battle drills in a manner consistent with suicide prevention principals.
Measured: Up to 24 months
Acceptability
Acceptability of Intervention Measure (AIM)
Measured: Up to 24 months
Appropriateness
Intervention appropriateness measure (IAM)
Measured: Up to 24 months
Qualitative Interviews
Qualitative Interviews (Acceptability, appropriateness, climate, etc.)
Measured: Up to 24 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Aug 2024
- Study start19 Mar 2025
- Primary completionSep 2027 (estimated)
- Study completionAug 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SuicideStudies of the same condition, open and under way.
- More trials run by University of PennsylvaniaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 57 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Pennsylvania
- Sponsor type
- University, hospital or other
- Collaborators
- Yale University
- Responsible party
- Sponsor
- Investigators
- Lily Brown, PhD, Principal investigator, University of PennsylvaniaAshley Hagaman, PhD, Principal investigator, Yale University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06547008
- Sponsor's protocol ID
- 855941
- Status last verified
- Oct 2026
- First submitted
- 11 Jul 2024
- Last updated
- 19 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: We will upload data into the NIMH Data Archives every 6 months.